Pricing Log in Create free account

Alvotech (ALVO) vs Amylyx Pharmaceuticals, Inc. (AMLX)

Alvotech and Amylyx Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Amylyx Pharmaceuticals, Inc. is the larger, with a market value of $3.5B against $2.1B — 1.7× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Alvotech leads on 8 and Amylyx Pharmaceuticals, Inc. on 6.

Valuation

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 5.02 33.52 2.11
P/B n/m 12.25 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 8.98 30.67 2.73
Earnings yield (23.93%) (5.43%) (4.38%)
Free cash flow yield (14.39%) (4.46%) 0.00%

Profitability

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
Gross margin 42.71% (42.65%) 53.94%
Operating margin (42.43%) 0.00% 0.00%
Net margin (101.05%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (74.73%) (0.40%)
Return on assets 0.00% (66.25%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (77.06%) 10.01%
EPS growth (last fiscal year) 111.49% 65.46% 49.06%
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.00 0.05
Current ratio 1.65 12.12 2.31
Net debt to EBITDA 9.71 2.00 0.97

Dividend

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ALVO AMLX Drug Manufacturers Specialty & Generic median
Market cap 2.07b 3.47b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack